Abstract 669: Sunitinib enhances TRAIL-induced apoptosis in preclinical colon cancer models
Devalingam Mahalingam(The University of Texas at San Antonio Health Science Center), Steffan T. Nawrocki(University of Arizona), Robbert H. Cool(University of Groningen), Jennifer S. Carew(University of Arizona), Ronan Swords(University of Miami), Steven de Jong(University Medical Center Groningen), Francis J. Giles(National University of Ireland), Sanjay Bansal(King's College Hospital), Kevin Kelly(The University of Texas at San Antonio Health Science Center), Ernest Medina(The University of Texas at San Antonio Health Science Center)
Cited by 0
Related Papers
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k
Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia
|Journal of Clinical Oncology|2005|951
Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics
|Clinical Cancer Research|2008|782